Tuberin expression in ganglioglioma

Ultrastructural Pathology

Volumn 24, Issue 2, 2000, Pages 93-98

  Arai, Yasuhiro ^a,b,c   Ackerley, Cameron A ^b   Becker, Laurence E ^b  

^a National Center of Neurology and Psychiatry   (Japan)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c National Center of Neurology and Psychiatry   (Japan)

Author keywords

Ganglioglioma; Hamartoma; TSC2 gene; Tuberin; Tumor suppressor

Indexed keywords

TUBERIN;

ADOLESCENT; ADULT; ARTICLE; ASTROCYTE; BRAIN TUMOR; CHILD; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; GLIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MEMBRANE BINDING; NISSL SUBSTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 0034058462     PISSN: 01913123     EISSN: None     Source Type: Journal    
DOI: 10.1080/01913120050118567     Document Type: Article

References (28)

1. 1. Chintagumpala MM, Armstrong D, Miki S, Nelson T, Cheek W, Laurent J, Woo SY, Mahoney DH Jr. Mixed neuronal-glial tumors (ganglioglioma) in children. Pediatr Neurosurg. 1996;24:306-313.
2. 2. Wolf HK, Muller MB, Spanle M, Zentner J, Schramm J, Wiestler OD. Ganglioglioma: a detailed histopathological and immunohistochemical analysis of 61 cases. Acta Neuropathol. 1994;88:166-173.
3. 3. Nakamura Y, Becker LE. Subependymal giant-cell tumor: astrocytic or neuronal? Acta Neuropathol. 1983;60:271-277.
4. 4. Kalyan Raman UP, Olivero WC. Ganglioglioma: a correlative clinicopathological and radiological study of ten surgically treated cases with follow-up. Neurosurgery. 1987;20:428-433.
5. 5. The European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of tuberous sclerosis gene on chromosome 16. Cell. 1993;75:1305-1315.
6. 6. Wienecke R, Konig A, DeClue JE. Identification of tuberin, the tuberous sclerosis-2 product: tuberin possesses specific Rap1 GAP activity. J Biol Chem. 1995;270:16409-16414.
7. 7. Soucek T, Holzl G, Bernaschek G, Hengstschlager M. A role of the tuberous sclerosis gene-2 product during neuronal differentiation. Oncogene. 1998;16:2197-2204.
8. 8. Soucek T, Pusch O, Wienecke R, DeClue, Hengstschlager M. Role of the tuberous sclerosis gene-2 product in cell cycle control: loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase. J Biol Chem. 1997;272:29301-29308.
9. 9. Mizuguchi M, Kato M, Yamanouchi H, Ikeda K, Takashima S. Loss of tuberin from cerebral tissues with tuberous sclerosis and astrocytoma. Ann Neurol. 1996;40:941-944.
10. 10. Mizuguchi M, Kato M, Yamanouchi H, Ikeda K, Takashima S. Tuberin immunohistochemistry in brain, kidneys and heart with or without tuberous sclerosis. Acta Neuropathol. 1997;94:525-531.
11. 11. Jay V, Becker LE, Otsubo H, Hwang PA, Hoffman HJ, Harwood-Nash D. Pathology of temporal lobectomy for refractory seizures in children: review of 20 cases including some unique malformative lesions. J Neurosurg. 1993;79:53-61.
12. 12. Arias C, Sharma N, Davies P, Shafit-Zagardo B. Okadaic acid induces early changes in microtuble-associated protein 2 and T phosphorylation prior to neurodegeneration in cultured cortical neurons. J Neurochem. 1993;61 :673-682.
13. 13. Diepholder HM, Schwechheimer K, Mohadjer M, Knoth R, Volk B. A clinicopathologic and immunomorphologic study of 13 cases of ganglioglioma. Cancer. 1991 ;68:2192-2201.
14. 14. Mickle JP. Ganglioglioma in children: a review of 32 cases at the University of Florida. Pediatr Neurosurg. 1992;18:310-314.
15. 15. Volk EE, Prayson RA. Hamartomas in the setting of chronic epilepsy: a clinicopathologic study of 13 cases. Hum Pathol. 1997;28:227-232.
16. 16. Prayson RA, Khajavi K, Comair YG. Cortical architectural abnormalities and MIB1 immunoreactivity in gangliogliomas: a study of 60 patients with intracranial tumors. J Neuropathol Exp Neurol. 1995;54:513-520.
17. 17. Gomez MR. Phenotypes of the tuberous sclerosis complex with a revision of diagnostic criteria. Ann NY Acad Sci. 1991 ;615:1-7.
18. 18. Henske EP, Neumann HPH, Scheithauer BW, Herbst EW, Short MP, Kwiatkowski DJ. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes Chromosomes Cancer. 1995;13:295-298.
19. 19. Wienecke R, Maize JC Jr, Shoarinejad F, et al. Co-localization of the TSC2 product tuberin with its target Rap1 in the golgi apparatus. Oncogene. 1996;13:913-923.
20. 20. Plank TL, Yeung RS, Henske EP. Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Cancer Res. 1998;58:4766-4770.
21. 21. Green AJ, Smith M, Yates JRW. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat Genet. 1994;6:193-196.
22. 22. Platten M, Meyer-Puttlitz B, Blumcke I, et al. A novel splice site associated polymorphism in the tuberous sclerosis 2 (TSC2) gene may predispose to the development of sporadic ganglioglioma. J Neuropath Exp Neurol. 1997;56:806-810.
23. 23. Smith DA, Lantos PL. Immunocytochemistry of cerebellar astrocytomas, with a special note on Rosenthal fibers. Acta Neuropathol. 1985;66:155-159.
24. 24. Iwai T, Iwai A, Tateishi J, Sasaki Y, Goldman JE. aB-crystallin and 27-kD heat shock protein are regulated by stress conditions in the central nervous system and accumulate in Rosenthal fibers. Am J Pathol. 1993;143:487-495.
25. 25. Lach B, Sikorska M, Rippstein P, Gregor A, Staines W, Davie TR. Immunoelectron microscopy of Rosenthal fibers. Acta Neuropathol. 1991; 81:563-509.
26. 26. Iwai T, Tateishi J. Immunohistochemical demonstration of alpha B-crystallin in hamartomas of tuberous sclerosis. Am J Pathol. 1991 ;139:1303-1308.
27. 27. Goldman JE, Corbin E. Isolation of a major protein component of Rosenthal fibers. Am J Pathol. 1988;130:569-578.
28. 28. Henske EP, Wessner LL, Golden J, et al. Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors. Am J Pathol. 1997;151:1639-1647.